At present, the global pharmaceutical gelatin market is growing continuously, and the largest markets are the Asia-Pacific region and North America. China is the world’s largest gelatin producer, and its gelatin production and export volume both rank first in the world. At the same time, with the improvement of people’s health awareness, more and more health care products and cosmetics begin to use medicinal gelatin as raw materials, which further expands the market demand for medicinal gelatin. In the next few years, it is expected that the pharmaceutical gelatin market will continue to maintain a good development trend.

The pharmaceutical gelatin market is expected to grow from USD 1.1 billion in 2022 to USD 1.5 billion in 2027, at a CAGR of 5.5%. According to the application, the pharmaceutical gelatin market is divided into hard capsules, soft capsules, tablets, absorbable hemostatic agents and other applications. Hard capsules will account for the largest share of the pharmaceutical gelatin market in 2021. Due to the advantages of fast drug release and uniform drug mixing, hard capsules have seen a growing demand for hard capsules globally, and this segment holds a large share.
The development trend of the medicinal gelatin industry points out that according to the source, the medicinal gelatin market is divided into pig, cowhide, beef bone, and fish. The pig market dominated in 2021 and is expected to grow at a significant CAGR during the forecast period. Porcine gelatin occupies a large share mainly due to its low cost, short production cycle, and high degree of application in the pharmaceutical market.
head
To sum up, the demand for medicinal gelatin in health care products and cosmetics continues to increase, which has promoted the increase in industrial scale and market share. Pharmaceutical gelatin is the most widely used in the field of capsules.